The Horseracing Integrity and Safety Authority will fund three scientific studies on the use of furosemide, also known as Lasix, on horses during the 48-hour period before the start of a covered horse ...

The choice of loop diuretic for decongestion in patients hospitalized with heart failure (HF) may make little difference to survival or readmission risk over the next year, at least when deciding ...

Credit: scPharmaceuticals. Furoscix is a pH-neutral formulation of furosemide, a loop diuretic, designed for SC administration via an on-body infusor for outpatient self-administration. Furoscix ® ...

The Horseracing Integrity and Safety Authority released a request for proposals July 30 for research into whether furosemide, more commonly known as Lasix, is a performance-enhancing drug in ...

CHICAGO, IL—The choice of loop diuretic doesn’t make a difference in how patients hospitalized for heart failure fare, at least when it comes to their risk of dying or of being readmitted, the ...

CHICAGO -- The choice between furosemide and torsemide didn't matter for longer-term clinical outcomes of hospitalized heart failure patients, according to the comparative effectiveness trial ...

The US Food and Drug Administration (FDA) has approved a furosemide preparation (Furoscix, scPharmaceuticals) intended for subcutaneous self-administration by outpatients with chronic heart failure ...

BURLINGTON, Mass., Oct. 8, 2025 /PRNewswire/ -- SQ Innovation, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its drug-device combination Lasix ® ONYU (furosemide ...

A Prescription Drug User Fee Act target date of March 6, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...